HOB Biotech Group Corp

HOB Biotech Group Corp Current Ratio

The Current Ratio of HOB Biotech Group Corp (688656.SS) as of Nov 15, 2026 is 1.73. In the previous year, Current Ratio was 1.25 — a change of 38.97% (higher).

Current Ratio

1.73

YoY

38.97%

Last updated:

Current Ratio of HOB Biotech Group Corp is 2025 1.73 . Current Ratio of HOB Biotech Group Corp was 2024 1.25 . It decreases by 38.97% higher compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

HOB Biotech Group Corp Stock analysis

What does HOB Biotech Group Corp do? HOB Biotech Group Corp Ltd generates revenue through the research, development, production, and sale of in-vitro diagnostic reagents, primarily targeting domestic markets. The company offers allergy testing products under brands Oboke, Fubok, Shibok, and Shibok Plus, utilizing qualitative detection techniques like enzyme-linked immunosorbent assay. Self-immune testing products are sold under Norbok and Nabok, employing quantitative methods such as enzyme-linked immunoassay capture and nano-magnetic particle chemiluminescence. Additional income comes from reagent supporting testing instruments and related services. The domestic market serves as the primary customer segment for HOB Biotech's products, with healthcare providers and laboratories purchasing allergy and self-immune testing solutions. Allergy testing brands Oboke, Fubok, Shibok, and Shibok Plus cater to qualitative detection needs, while Norbok and Nabok address quantitative detection requirements for self-immune testing. The company's product portfolio is structured around these distinct brand categories and detection techniques. HOB Biotech's revenue streams are derived from the sale of branded diagnostic reagents and supporting instruments, with no mention of external partnerships or international markets. The firm focuses exclusively on domestic sales, leveraging its two product categories and five distinct brands to serve healthcare institutions requiring in-vitro diagnostic solutions. HOB Biotech Group Corp is one of the most popular companies on Eulerpool.

Frequently Asked Questions about HOB Biotech Group Corp stock

Current Ratio of HOB Biotech Group Corp is 1.73 in 2025.

Current Ratio of HOB Biotech Group Corp changed from 1.25 to 1.73, representing a 38.97% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Ratio HOB Biotech Group Corp since 2006 – with annual values, charts, and detailed analysis.

The Current Ratio measures a company's ability to pay short-term obligations. A ratio above 1 indicates that current assets exceed current liabilities.

Current Ratio = Current Assets / Current Liabilities

A 'good' varies by industry and company stage. On Eulerpool, you can compare Current Ratio's HOB Biotech Group Corp with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — HOB Biotech Group Corp

All Key Metrics — HOB Biotech Group Corp